Categories Earnings, Health Care
Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit.
- Revenues increased 13% year-over-year to $53.5 billion in the final three months of fiscal 2023
- Fourth-quarter operating earnings came in at $137 million, sharply higher than the $36 million reported a year earlier
- The company reported a net loss of $64 million or $0.25 per share for Q4, compared to a profit of $138 million or $0.50 per share last year
- On an adjusted basis, it was a profit of $1.55 per share, compared to $1.05 per share in the same quarter of 2022
- The Pharmaceutical segment profit increased 12% to $504 million and Medical segment profit rose to $82 million
- The company generated both operating cash flow and adjusted free cash flow of $2.8 billion in Q4
- The management raised its fiscal 2024 adjusted EPS guidance to the range of $6.50 to $6.75, from $6.45-$6.70
Most Popular
After a weak first half, will NIKE (NKE) hit the recovery path this year?
After a prolonged slowdown, NIKE, Inc. (NYSE: NKE) is working on a turnaround plan to regain the brand’s strength. In recent years, the sneaker giant’s overall performance has not been
Important takeaways from Paychex’s (PAYX) Q2 2025 earnings report
Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, reported better-than-expected revenue and profit for the second quarter of fiscal 2025, sending the stock higher soon
Lamb Weston’s (LW) challenges may not end soon, a few points to note
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) turned red in mid-day trade on Friday. The stock has dropped 19% in the past one month. The company delivered disappointing results
